Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study (2023)
Attributed to:
Data mining epidemiological relationships: integration of causal analysis with published evidence
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1003988
Publication URI: http://dx.doi.org/10.1371/journal.pmed.1003988
Type: Journal Article/Review
Parent Publication: PLOS Medicine
Issue: 1